In addition to this immunomodulatory effect, HCQ can have a direct antiviral effect in vitro by modifying membrane fusion receptors, preventing the cellular penetration of coronaviruses while interfering with the glycosylation of angiotensin-converting enzyme, a cellular receptor for COVID-19. This evidence concerns the gene ACE and COVID-19.